EVMN

Evommune, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$8.02

Price (1 Year)

$31.57 $5.1

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0.1 / %30
Non-compliant assets / Total market cap %31.2 / %30
Non-compliant revenue / Total income %100 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis.

Website

Analysis (Turkish): EVMN Hissesi Caiz mi, Helal mi? Evommune, Inc. Katılım Analizi